Trial Profile
An Open-label, Single-sequence Study to Assess the Effect of Multiple Doses of Tradipitant on Cytochrome P450 3A4 Using Midazolam as a Substrate in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tradipitant (Primary) ; Midazolam
- Indications Pruritus
- Focus Pharmacokinetics
- Sponsors Vanda Pharmaceuticals
- 26 Apr 2016 Status changed from recruiting to completed.
- 08 Dec 2015 New trial record